In recent decades, the biomedical applications of mesenchymal stem cells (MSCs) have
attracted increasing attention. MSCs are easily extracted from the bone marrow, fat, and …

Mesenchymal stem cells (MSCs) are promising alternative agents for the treatment of
inflammatory disorders due to their immunomodulatory functions, and several clinical trials …

Effective countermeasures for tendon injury remains unsatisfactory. Mesenchymal stem cell-
derived extracellular vesicles (MSC-EVs)-based therapy via regulation of Mφ-mediated …

Ligament and tendon injuries are common problems in orthopedics. There is a need for
treatments that can expedite nonoperative healing or improve the efficacy of surgical repair …

Mesenchymal stem cells (MSCs) hold great potential as a regenerative therapy for stroke,
leading to increased repair and functional recovery in animal models of cerebral ischaemia …

Immunotherapy has been recognized for decades as a promising therapeutic method for
cancer treatment. To enhance host immune responses against cancer, antigen‐presenting …

Tendon healing follows a complex series of coordinated events, which ultimately produces a
mechanically inferior tissue more scar-like than native tendon. More regenerative healing …

Background Immunoregulatory capacity of mesenchymal stem cells (MSC) is triggered by
the inflammatory environment, which changes during tissue repair. Macrophages are …

Background Inflammation after tendon-bone junction injury results in the formation of
excessive scar tissue and poor biomechanical properties. Recent research has shown that …

Adult tendon tissue demonstrates a limited regenerative capacity, and the natural repair
process leaves fibrotic scar tissue with inferior mechanical properties. Surgical treatment is …